These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Holter monitoring comparative assessment of propafenone and dihydroquinidine efficacy in the treatment of premature ventricular beats. Rizzon P, De Toma L, Mangini SG, Scrutinio D, Lagioia R, De Nicolò M. Cardiologia; 1983 Sep; 28(9):791-801. PubMed ID: 6398703 [No Abstract] [Full Text] [Related]
3. Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration. Chimienti M, Regazzi MB, La Rovere MT, Salerno JA, Previtali M, Montericcio V, Rondanelli R, Montemartini C. Cardiovasc Drugs Ther; 1988 Dec; 2(5):679-86. PubMed ID: 2484920 [Abstract] [Full Text] [Related]
5. [Therapy of ventricular arrhythmias with propafenone]. Petri H, Kafka W, Rudolph W. Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879 [Abstract] [Full Text] [Related]
6. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG]. Ferrara E, Vitali A, Cucchi GF. Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385 [No Abstract] [Full Text] [Related]
7. [Value of propafenon in the control of ventricular extrasystolic arrhythmia. Clinical, electrocardiographic and laboratory evaluation in prolonged use]. Giannini SD, Zillioto EE, Campanari JC, Formicola A. Arq Bras Cardiol; 1980 Dec; 35(6):525-8. PubMed ID: 6167246 [No Abstract] [Full Text] [Related]
9. [Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system]. de Brito FS, Pereira MH, Castro I, Maia IG. Arq Bras Cardiol; 1979 Oct; 33(4):303-10. PubMed ID: 94993 [No Abstract] [Full Text] [Related]
10. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment]. Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P. G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383 [Abstract] [Full Text] [Related]
12. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms]. Mastropasqua F, Totaro P, Massari F, Pitzalis MV, Rizzon P. Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961 [Abstract] [Full Text] [Related]
16. [Propafenone in refractory supraventricular arrhythmias]. Palumbo E, Svetoni N, Casini M, Spargi T, Biagi G, Lanzetta T. G Ital Cardiol; 1984 May; 14(5):381-2. PubMed ID: 6468822 [Abstract] [Full Text] [Related]
17. [Disturbances of potency and spermiogenesis due to propafenon (author's transl)]. Körst HA, Brandes JW, Littmann KP. Dtsch Med Wochenschr; 1980 Aug 22; 105(34):1187-9. PubMed ID: 6161769 [Abstract] [Full Text] [Related]
18. Dose-related antiarrhythmic effects of nicainoprol in patients with chronic ventricular arrhythmias--a double-blind, placebo-controlled, cross-over multicentre trial. Nicainoprol Study Group. Schneider W, Reifart N, Blaeser A, Ostrowski J, Kaltenbach M, Kober G. Eur Heart J; 1991 Aug 22; 12(8):900-8. PubMed ID: 1915428 [Abstract] [Full Text] [Related]
19. [Holter analysis of ventricular arrhythmias and its treatment with propafenone]. Peralta Heredia R. Arch Inst Cardiol Mex; 1986 Aug 22; 56(3):225-30. PubMed ID: 2428317 [Abstract] [Full Text] [Related]
20. [Antiarrhythmic drugs in chronic ventricular extrasystole (author's transl)]. Klein G, Wirtzfeld A, Schlegel J, Himmler C, Neiss A. Dtsch Med Wochenschr; 1980 Feb 08; 105(6):189-94. PubMed ID: 6153310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]